CRL expands cancer model offering with p53 and BCrp rats
Charles River Laboratories (CRL) has added two new exclusive knockout rats to its preclinical development offering in deal with Transposagen Biopharmaceuticals.
Charles River Laboratories (CRL) has added two new exclusive knockout rats to its preclinical development offering in deal with Transposagen Biopharmaceuticals.
The Contract Research Organisation (CRO), Siro Clinpharm, has added the management system “On Trak” to its capabilities in India.
The FDA is to collaborate with the WHO to build a global surveillance and monitoring system for combating falsified medicines and breaches of the supply chain.
BioFocus has sealed two compound management deals with the National Cancer Institute and eMolecules, while extending its relationship with Chiesi Farmaceutici for $3.5m (€2.5m).
Biopharm sees a large future for packaging containing digital codes that can link mobile devices to content, according to Catalent.
Stemedica and AnC Bio have formed a joint venture to manufacture stem cells for the treatment of ischemic stroke and other degenerative disorders.